Enzyme polymorphism in warfarin dose management after pediatric cardiac surgery
Background: Warfarin is an anticoagulant and is widely used for the prevention of thromboembolic events. Genetic variants of the enzymes that metabolize warfarin, i.e. cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1), contribute to differences in patients’ responses to various w...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Series: | Research in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2015;volume=4;issue=3;spage=10;epage=10;aulast=Tabib;type=0 |